recently demonstrated that cholesterol inhibits the autophagic degradation of receptor tyrosine kinases in human liver cancer cells by interfering with the function of GOLM1 (Golgi membrane protein 1) (58). The gene discussed is GOLM1; the disease is liver cancer.